First-line pembrolizumab monotherapy met the primary end point of PFS in dMMR advanced/recurrent endometrial cancer.
|Videos|May 9, 2011
Intraperitoneal Struggles in Ovarian Cancer Treatments
Author(s)Fiona McCaughan, RN, MS
Oncology Nurse Fiona McCaughan on Struggles Facing Intraperitoneal Ovarian Cancer Treatments
Advertisement
Fiona McCaughan, RN, MS, OCN, Hematology Oncology Nurse at Winchester Hospital in Stoughton, MA on Struggles Facing Intraperitoneal Ovarian Cancer Treatments
Advertisement
Related to this article
In case you missed any, check out our recap of the episodes of OncLive On Air that aired in June 2026.
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL
4
Dr Falchi on Critical Unmet Needs and Important Next Steps in DLBCL
5